Exisulind

Exisulind induces apoptosis through the activation of protein kinase G (PKG) . Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.